Skip to main content
FHI
NYSE Finance

CFO Sells $1.7 Million in Federated Hermes Stock Near 52-Week Highs

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Asset Management Stocks · Financial
Sentiment info
Negative
Importance info
7
Price
$56.6
Mkt Cap
$4.3B
52W Low
$35.05
52W High
$57.8
52W Position info
61% above low
Off High info
2.1% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

FHI sits 61% above its 52-week low of $35.05.

Summary

Federated Hermes' CFO and Director, Thomas R. Donahue, sold 30,000 shares of company stock for over $1.7 million, marking a significant insider disposition while the stock trades near its 52-week high.


Key Events · Ownership and Investor Activity · FHI

  • CFO Sells Significant Stake

    Thomas R. Donahue, CFO, VP, and Director, disposed of 30,000 shares of Class B Common Stock in an open market transaction.

  • Over $1.7 Million in Proceeds

    The sale, executed on March 13, 2026, generated total proceeds of $1,713,087 at an average price of $57.10 per share.

  • Sale Near 52-Week High

    The transaction occurred while Federated Hermes stock was trading near its 52-week high, potentially indicating the insider capitalizing on favorable market conditions.

  • Contributes to Insider Distribution Trend

    This sale adds to a net insider selling trend of over $2 million in open market transactions over the last 90 days.


Analysis · FHI · Finance

This Form 4 filing reports a substantial open market sale by Thomas R. Donahue, who serves as CFO, VP, and Director of Federated Hermes. The sale of 30,000 shares, valued at over $1.7 million, represents a notable disposition by a key executive. This transaction contributes to a broader pattern of insider selling observed over the past 90 days, totaling over $2 million. The sale occurred on March 13, 2026, when the stock was trading near its 52-week high, which could be interpreted as the insider capitalizing on favorable market conditions. Investors may view this as a negative signal, indicating a lack of conviction at current price levels, despite the company's recent strong financial performance reported in its Q4 and full-year 2025 earnings.

At the time of this filing, FHI was trading at $56.60 on NYSE in the Finance sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $35.05 to $57.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FHI - Latest Insights

FHI
Jun 17, 2026, 9:20 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $58.75
Real-time Price: $60.52 info
Change: +$1.77 (+3%) info
Market Cap: $4.595B info
FHI
Jun 08, 2026, 4:17 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $56.95
Real-time Price: $60.52 info
Change: +$3.57 (+6%) info
Market Cap: $4.595B info
FHI
May 07, 2026, 4:11 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $54.34
Real-time Price: $60.52 info
Change: +$6.18 (+11%) info
Market Cap: $4.595B info
FHI
May 01, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $54.12
Real-time Price: $60.52 info
Change: +$6.40 (+12%) info
Market Cap: $4.595B info
FHI
Apr 30, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $58.09
Real-time Price: $60.52 info
Change: +$2.43 (+4%) info
Market Cap: $4.595B info